Performance Evaluation of the PowerChek MERS (upE & ORF1a) Real-Time PCR Kit for the Detection of Middle East Respiratory Syndrome Coronavirus RNA
- PMID: 28840986
- PMCID: PMC5587821
- DOI: 10.3343/alm.2017.37.6.494
Performance Evaluation of the PowerChek MERS (upE & ORF1a) Real-Time PCR Kit for the Detection of Middle East Respiratory Syndrome Coronavirus RNA
Abstract
Background: Molecular detection of Middle East respiratory syndrome coronavirus (MERS-CoV) using real-time reverse transcription (rRT)-PCR assays is the method of choice for diagnosis of MERS. We evaluated the performance of the PowerChek MERS (upE & ORF1a) real-time PCR Kit (PowerChek MERS assay; Kogene Biotech, Korea) a one-step rRT-PCR assay for the qualitative detection of MERS-CoV.
Methods: We evaluated PowerChek MERS assay performance in comparison with nested RT-PCR and sequencing of the RNA-dependent RNA polymerase (RdRp) and N genes. To evaluate diagnostic sensitivity and specificity, 100 clinical specimens (50 positive and 50 negative for MERS-CoV) were simultaneously tested by using the PowerChek MERS and sequencing assays. Assay performance, including limit of detection and precision, was evaluated in vitro by using MERS-CoV RNA transcripts. Analytical specificity was evaluated with a diverse collection of 16 respiratory virus-positive clinical specimens and 14 respiratory bacterial isolates.
Results: The 95% limits of detection of the PowerChek MERS assay for the upE and the open rading frame (ORF)1a were 16.2 copies/μL and 8.2 copies/μL, respectively. No cross-reactivity was observed. The diagnostic sensitivity and specificity of the PowerChek MERS assay were both 100% (95% confidence interval, 91.1-100%).
Conclusions: The PowerChek MERS assay is a straightforward and accurate assay for detecting MERS-CoV RNA. The assay will be a useful tool for the rapid diagnosis of MERS and could prove especially important for MERS outbreak control.
Keywords: MERS-CoV; Performance; Real-time reverse-transcription PCR.
© The Korean Society for Laboratory Medicine
Conflict of interest statement
No potential conflicts of interest relevant to this article were reported.
Similar articles
-
Analytical and Clinical Validation of Six Commercial Middle East Respiratory Syndrome Coronavirus RNA Detection Kits Based on Real-Time Reverse-Transcription PCR.Ann Lab Med. 2016 Sep;36(5):450-6. doi: 10.3343/alm.2016.36.5.450. Ann Lab Med. 2016. PMID: 27374710 Free PMC article.
-
External Quality Assessment of MERS-CoV Molecular Diagnostics During the 2015 Korean Outbreak.Ann Lab Med. 2016 May;36(3):230-4. doi: 10.3343/alm.2016.36.3.230. Ann Lab Med. 2016. PMID: 26915611 Free PMC article.
-
Evaluation of a Real-Time Reverse Transcription-PCR (RT-PCR) Assay for Detection of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Clinical Samples from an Outbreak in South Korea in 2015.J Clin Microbiol. 2017 Aug;55(8):2554-2555. doi: 10.1128/JCM.00667-17. Epub 2017 May 31. J Clin Microbiol. 2017. PMID: 28566313 Free PMC article. No abstract available.
-
MERS-CoV diagnosis: An update.J Infect Public Health. 2016 May-Jun;9(3):216-9. doi: 10.1016/j.jiph.2016.04.005. Epub 2016 Apr 20. J Infect Public Health. 2016. PMID: 27106390 Free PMC article. Review.
-
Korean Society for Laboratory Medicine Practice Guidelines for the Molecular Diagnosis of Middle East Respiratory Syndrome During an Outbreak in Korea in 2015.Ann Lab Med. 2016 May;36(3):203-8. doi: 10.3343/alm.2016.36.3.203. Ann Lab Med. 2016. PMID: 26915607 Free PMC article. Review.
Cited by
-
Clinical Characteristics, Diagnosis, and Treatment of Major Coronavirus Outbreaks.Front Med (Lausanne). 2020 Nov 13;7:581521. doi: 10.3389/fmed.2020.581521. eCollection 2020. Front Med (Lausanne). 2020. PMID: 33282890 Free PMC article. Review.
-
Diagnostic Techniques for COVID-19: A Mini-review of Early Diagnostic Methods.J Anal Test. 2021;5(4):314-326. doi: 10.1007/s41664-021-00198-5. Epub 2021 Oct 4. J Anal Test. 2021. PMID: 34631199 Free PMC article. Review.
-
SARS-CoV, MERS-CoV and SARS-CoV-2: A Diagnostic Challenge.Measurement (Lond). 2021 Jan 15;168:108335. doi: 10.1016/j.measurement.2020.108335. Epub 2020 Aug 8. Measurement (Lond). 2021. PMID: 33519010 Free PMC article.
-
Characterization of a human monoclonal antibody generated from a B-cell specific for a prefusion-stabilized spike protein of Middle East respiratory syndrome coronavirus.PLoS One. 2020 May 8;15(5):e0232757. doi: 10.1371/journal.pone.0232757. eCollection 2020. PLoS One. 2020. PMID: 32384116 Free PMC article.
-
Evaluation of visual triage for screening of Middle East respiratory syndrome coronavirus patients.New Microbes New Infect. 2018 Aug 11;26:49-52. doi: 10.1016/j.nmni.2018.08.008. eCollection 2018 Nov. New Microbes New Infect. 2018. PMID: 30224971 Free PMC article.
References
-
- World Health Organization. Laboratory testing for Middle East respiratory syndrome coronavirus (MERT-CoV). Interim guidance. [Updated on June 2015]. http://www.who.int/csr/disease/coronavirus_infections/mers-laboratory-te...
-
- Corman VM, Eckerle I, Bleicker T, Zaki A, Landt O, Eschbach-Bludau M, et al. Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction. Euro Surveill. 2012;17:pii:20285. - PubMed
-
- Corman VM, Müller MA, Costabel U, Timm J, Binger T, Meyer B, et al. Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill. 2012;17:pii:20334. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials